Lect 1 introduction_to_dosage_form_design_
0 likes162 views
This document provides an introduction to dosage form design. It discusses the aims of the course, which are to explain pharmaceutical processing, drug formulation, and biopharmaceutics. It also discusses why a dosage form is needed for a drug and lists some key terms related to dosage form design. The document notes that three main factors contribute to designing an effective dosage form: dosage form related factors, drug related factors, and physiological factors. It provides examples of common dosage forms that will be considered, including solid, liquid, gas delivery, semisolid, transdermal, sustained release, and sterile products.
1 of 5
Download to read offline
Recommended
Absolute bioavailability & relative bioavailability
Absolute bioavailability & relative bioavailabilityMahesh Gomasa
油
This document discusses absolute and relative bioavailability. Absolute bioavailability is determined for the same drug in various formulations and measures the actual percentage of an administered non-intravenous dose that is absorbed into systemic circulation relative to an equivalent intravenous dose. Relative bioavailability compares drug exposures following extravascular administration to that of intravenous administration and is used to characterize a drug's inherent absorption properties from extravascular sites. Relative bioavailability compares the bioavailability of formulations of the same drug, usually to an established standard formulation.Methods of improving bioavailability
Methods of improving bioavailabilitypharmacampus
油
Bioavailability studies are designed to determine either an absolute BA or relative BA.
They can be used to compare different routes of administration.
Important questions Of Pharmaceutics According to PCI Syllabus
Important questions Of Pharmaceutics According to PCI SyllabusPayaamvohra1
油
This ppt gives an idea about frequently asked questions of Pharmaceutics tips tricks concepts for learning pharmacy .Do checkout the other ppt for mnemonics of other subjects Bioavailability and bioequivalence testing
Bioavailability and bioequivalence testingsuhasini
油
This document discusses bioavailability and bioequivalence testing. It defines bioavailability as the relative amount of an administered dose that reaches systemic circulation. Bioavailability can be measured using pharmacokinetic methods like plasma level time studies and urinary excretion studies. Factors that affect bioavailability include formulation factors, excipients, drug properties, and physiological factors. Bioequivalence refers to two drug products containing the same active ingredient reaching systemic circulation at the same rate and to the same extent. Statistical tests are used to determine bioequivalence based on pharmacokinetic parameters. Methods to enhance bioavailability include altering particle size, adding surfactants, changing pH, and using solubilizing formulations like solid dispersions.Dosage from
Dosage fromDileep Singh Baghel
油
This document provides an overview of the pharmaceutical industry from drug discovery through delivery to patients. It discusses how active pharmaceutical ingredients are formulated into dosage forms along with excipients for safe and effective delivery. Various dosage forms are classified by route of administration and physical form. The document also outlines considerations for drug development including effectiveness, safety, stability, and consumer acceptance. It briefly discusses pharmacokinetics, therapeutic use, adverse effects, regulations, and standards for quality evaluation of drugs.Significance of bioavailability Studies
Significance of bioavailability StudiesMuhammad Abdul Salam
油
Significance of bioavailability Studies
Importance of bioavailability Studies
Advantages bioavailability StudiesSolubility estimation 
Solubility estimation Nilesh Kulkarni
油
Dr. Nilesh Kulkarni discusses solubility and the Biopharmaceutics Classification System (BCS). The BCS classifies drugs based on their aqueous solubility and intestinal permeability. It divides drugs into four classes. Solubility can be improved through methods like reducing particle size, modifying crystal habit through polymorphism or amorphous forms, or forming salts. A drug's solubility is important for its dissolution and absorption.Eiropas Jaunie邸u parlaments
Eiropas Jaunie邸u parlamentsCentre for Public Policy PROVIDUS
油
Prezentcija seminra izgl朝t朝bas iest転u vad朝tjiem par aktuliem Eiropas Savien朝bas jautjumiem ietvaros, ko organizja Latvijas Republikas rlietu ministrija sadarb朝b ar Eiropas Parlamenta informcijas biroju Latvij, Eiropas Komisijas prstvniec朝bu Latvij un sabiedrisks politikas centru PROVIDUS 2013.gada 30.apr朝l朝 un 2.maij.
Pla邸ka informcija: http://www.providus.lv/public/27835.html pharmaceutics dosage form design chapt-4 
pharmaceutics dosage form design chapt-4 Areej Abu Hanieh
油
Pharmaceutics is the science of dosage form design and drug delivery. It draws from many disciplines to understand how drugs interact inside and outside the body. The goal is to design safe and effective dosage forms for drugs' intended uses. Dosage form design considers the drug's physicochemical properties, biopharmaceutical factors like absorption site, and logistical factors like storage stability. It is important to deliver drugs via dosage forms that provide accurate dosing, protect unstable drugs, and facilitate optimal drug action based on route of administration. Proper dosage form design allows drugs to be delivered safely and effectively.introduction.pptx
introduction.pptxAhmadHashlamon
油
drug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesPHARMACEUTICS.pptx
PHARMACEUTICS.pptxPlexDon
油
This document provides an introduction to pharmaceutics, which is concerned with the preparation and use of medicinal drugs. It discusses key topics including:
- The sources of drugs, pharmacology analysis, and active ingredients
- The design and manufacture of dosage forms, which combine active ingredients with excipients to facilitate drug delivery
- Quality assurance processes to ensure safe and effective drug production in a consistent manner
- The six main areas of pharmaceutics including physical chemistry principles, biopharmaceutics, dosage form design, manufacturing processes, sterilization, and product testing
- Factors considered in dosage form design like drug properties, administration route requirements, and therapeutic indicationsINTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN).ppt
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN).pptMohammadJavedAnsari1
油
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN)
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN)
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN)
Dosage form design
Dosage form designtamjid hossain
油
This document discusses pharmaceutical technology and considerations for developing drug dosage forms. Pharmaceutical technology deals with formulating new chemical entities into safe and effective medications for patients. Medicines contain drug substances formulated with excipients into dosage forms for delivery. Different dosage forms serve various purposes like protecting drugs, masking tastes, providing liquids or controlled release. Major considerations in designing dosage forms include physicochemical properties, biochemistry, and determining the optimal product type based on development goals. Therapeutic factors are also assessed like treatment type and patient attributes to select the appropriate dosage form.01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdf
01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdfMaicon Andr辿 Goularte
油
This presentation has some basical concepts related to pharmaceutical production and the terminology used in this industrial sector.fda
fdaGeorgi Daskalov
油
This document summarizes a presentation given by Robert Lionberger on novel methods for demonstrating pharmaceutical equivalence and bioequivalence for complex drug products. It discusses the new Office of Research and Standards within the Office of Generic Drugs at FDA, which facilitates pre-ANDA development and conducts regulatory science research. It also describes challenges with evaluating generic versions of complex drugs like liposomes, inhalation products, and topical dermatological products. The presentation outlines FDA's research on evaluating these complex generics and developing new guidance through regulatory science approaches.Rx15 clinical tues_200_1_bianchi_2saenger
Rx15 clinical tues_200_1_bianchi_2saengerOPUNITE
油
This document summarizes presentations from a clinical track on decreasing opioid risks and exploring non-opioid options for pain management. It discusses the FDA and VA's responses to the opioid epidemic through decreasing opioid prescribing and exploring alternatives. Robert Bianchi discusses the FDA's guidance for developing abuse-deterrent opioids and evaluating claims about abuse-deterrence through laboratory studies. Michael Saenger discusses applying a biopsychosocial model to chronic pain diagnosis and treatment rather than a biomedical model, using a coaching approach to self-management, and applying neuroplasticity principles. The document emphasizes considering the whole person and moving away from a focus on prescription opioids for chronic pain.
Pharmaceutical excipients
Pharmaceutical excipientsHossen M. Faruk
油
The document discusses pharmaceutical excipients. It provides an overview of excipients, noting that drug products contain both active pharmaceutical ingredients and excipients. Excipients are chosen to ensure efficacious drug products with desired properties, a robust manufacturing process, consistency of drug release and bioavailability, and stability. Excipients are classified based on their functional roles. They must be manufactured and quality controlled according to good manufacturing practices and can impact drug product quality. International guidelines provide requirements for new excipients and limits on impurities and residual solvents.tablets_part_1.pdf
tablets_part_1.pdfHebaYassin10
油
This document provides objectives and content for a chapter on tablet dosage forms. It begins by listing 7 learning objectives for students related to different tablet types, ingredients, and modified release forms. It then covers various topics on tablet dosage forms including definitions of immediate and modified release tablets, important ingredients like fillers, binders, and disintegrants, factors that influence powder compaction, and mechanisms of drug release from tablets. The document aims to educate students on the development, formulation, and performance of oral tablet dosage forms.Posology and dosage regimen
Posology and dosage regimenSandeepkarki13
油
It includes the detail information about the different dosage form along with its example and the factors affecting the choice of different dosage form.understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...MaryRoseFraga
油
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics-and-their-clinical-applications.pdfpatrial
patrialNadia Nabila Anam Arin
油
The document provides an overview of oral controlled release drug delivery systems. It discusses the anatomy and physiology related to oral drug administration. Some key advantages of controlled release oral dosage forms are enhanced bioavailability, reduced dosing frequency, and more consistent drug levels in the body. The document also covers various mechanisms for controlled release, including osmotic pumps, floating systems, and coating technologies. It provides examples of commercially available controlled release drugs and classifications of these systems.biopharmaceutices introduction.pptx
biopharmaceutices introduction.pptxanumalagundam sreekanth
油
Biopharmaceutics studies the impact of drug and drug product properties on delivery and performance in the body. The aim is to design drug products that provide optimal therapeutic effects and safety. Key considerations include drug bioavailability, properties like solubility that impact absorption, and dosage form design to deliver drugs effectively based on their characteristics and intended effects. Drug product design incorporates pharmacokinetic, manufacturing, and patient factors to successfully deliver therapeutic doses of drugs.Therequiv
Therequivcqpate
油
Bioavailability and bioequivalence are important concepts for regulating generic drugs. Bioavailability refers to the rate and extent that the active drug ingredient is absorbed and available in the body. Bioequivalence means two drug products containing the same active ingredient have the same rate and extent of absorption. For approval, generic drugs must demonstrate bioequivalence to the brand name drug through pharmacokinetic studies comparing metrics like AUC and Cmax between a test and reference drug. The FDA prefers showing bioequivalence through these types of studies using a crossover design in healthy subjects under fasted conditions.
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfShaikh Abusufyan
油
This document provides an introduction to pharmacology. It defines key terms like pharmacology, pharmacodynamics, pharmacokinetics, and discusses the history and divisions of pharmacology. It also covers drug nomenclature, essential medicines, orphan drugs, and provides definitions of related terms like pharmacy, pharmaceutics, and toxicology. The document is presented by Prof. Shaikh Abusufiyan and aims to explain fundamental concepts in pharmacology to students.Bioavailability & Bioequivalance
Bioavailability & BioequivalanceVNS Group of Institutions - Faculty of Pharmacy, Bhopal (M.P.) India
油
This document discusses bioavailability and bioequivalence. It defines bioavailability as the rate and extent of drug absorption into systemic circulation from its dosage form. Bioequivalence is established when two similar dosage forms reach systemic circulation at the same relative rate and extent. The objectives, significance, and various study designs of bioavailability testing are described, including absolute vs relative bioavailability. Methods for measuring bioavailability and various in vitro drug dissolution models are also summarized.Application of bio-pharmaceutics in the pharmaceutical industry
Application of bio-pharmaceutics in the pharmaceutical industryMd. Masum Billah
油
This presentation discusses the application of bio-pharmaceutics in the pharmaceutical industry. It defines bio-pharmaceutics as the study of a drug's physical and chemical properties and how they relate to the drug's effects over time. The presentation covers pharmacodynamics, pharmacokinetics, and some key applications including dose, dosage form, bioavailability, bioequivalence, and new drug development. It also discusses concepts such as volume of distribution, distribution coefficient, and organ-specific clearance.More Related Content
Similar to Lect 1 introduction_to_dosage_form_design_ (20)
pharmaceutics dosage form design chapt-4
pharmaceutics dosage form design chapt-4 Areej Abu Hanieh
油
Pharmaceutics is the science of dosage form design and drug delivery. It draws from many disciplines to understand how drugs interact inside and outside the body. The goal is to design safe and effective dosage forms for drugs' intended uses. Dosage form design considers the drug's physicochemical properties, biopharmaceutical factors like absorption site, and logistical factors like storage stability. It is important to deliver drugs via dosage forms that provide accurate dosing, protect unstable drugs, and facilitate optimal drug action based on route of administration. Proper dosage form design allows drugs to be delivered safely and effectively.introduction.pptx
introduction.pptxAhmadHashlamon
油
drug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesdrug capsulesPHARMACEUTICS.pptx
PHARMACEUTICS.pptxPlexDon
油
This document provides an introduction to pharmaceutics, which is concerned with the preparation and use of medicinal drugs. It discusses key topics including:
- The sources of drugs, pharmacology analysis, and active ingredients
- The design and manufacture of dosage forms, which combine active ingredients with excipients to facilitate drug delivery
- Quality assurance processes to ensure safe and effective drug production in a consistent manner
- The six main areas of pharmaceutics including physical chemistry principles, biopharmaceutics, dosage form design, manufacturing processes, sterilization, and product testing
- Factors considered in dosage form design like drug properties, administration route requirements, and therapeutic indicationsINTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN).ppt
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN).pptMohammadJavedAnsari1
油
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN)
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN)
INTRODUCTION TO PHARMACEUTICS 1 (PHYSICAL PHARMACY-DOSAGE FORM DESIGN)
Dosage form design
Dosage form designtamjid hossain
油
This document discusses pharmaceutical technology and considerations for developing drug dosage forms. Pharmaceutical technology deals with formulating new chemical entities into safe and effective medications for patients. Medicines contain drug substances formulated with excipients into dosage forms for delivery. Different dosage forms serve various purposes like protecting drugs, masking tastes, providing liquids or controlled release. Major considerations in designing dosage forms include physicochemical properties, biochemistry, and determining the optimal product type based on development goals. Therapeutic factors are also assessed like treatment type and patient attributes to select the appropriate dosage form.01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdf
01._INTRODUCTION_TO_Pharmaceutical_technology_2017.pdfMaicon Andr辿 Goularte
油
This presentation has some basical concepts related to pharmaceutical production and the terminology used in this industrial sector.fda
fdaGeorgi Daskalov
油
This document summarizes a presentation given by Robert Lionberger on novel methods for demonstrating pharmaceutical equivalence and bioequivalence for complex drug products. It discusses the new Office of Research and Standards within the Office of Generic Drugs at FDA, which facilitates pre-ANDA development and conducts regulatory science research. It also describes challenges with evaluating generic versions of complex drugs like liposomes, inhalation products, and topical dermatological products. The presentation outlines FDA's research on evaluating these complex generics and developing new guidance through regulatory science approaches.Rx15 clinical tues_200_1_bianchi_2saenger
Rx15 clinical tues_200_1_bianchi_2saengerOPUNITE
油
This document summarizes presentations from a clinical track on decreasing opioid risks and exploring non-opioid options for pain management. It discusses the FDA and VA's responses to the opioid epidemic through decreasing opioid prescribing and exploring alternatives. Robert Bianchi discusses the FDA's guidance for developing abuse-deterrent opioids and evaluating claims about abuse-deterrence through laboratory studies. Michael Saenger discusses applying a biopsychosocial model to chronic pain diagnosis and treatment rather than a biomedical model, using a coaching approach to self-management, and applying neuroplasticity principles. The document emphasizes considering the whole person and moving away from a focus on prescription opioids for chronic pain.Pharmaceutical excipients
Pharmaceutical excipientsHossen M. Faruk
油
The document discusses pharmaceutical excipients. It provides an overview of excipients, noting that drug products contain both active pharmaceutical ingredients and excipients. Excipients are chosen to ensure efficacious drug products with desired properties, a robust manufacturing process, consistency of drug release and bioavailability, and stability. Excipients are classified based on their functional roles. They must be manufactured and quality controlled according to good manufacturing practices and can impact drug product quality. International guidelines provide requirements for new excipients and limits on impurities and residual solvents.tablets_part_1.pdf
tablets_part_1.pdfHebaYassin10
油
This document provides objectives and content for a chapter on tablet dosage forms. It begins by listing 7 learning objectives for students related to different tablet types, ingredients, and modified release forms. It then covers various topics on tablet dosage forms including definitions of immediate and modified release tablets, important ingredients like fillers, binders, and disintegrants, factors that influence powder compaction, and mechanisms of drug release from tablets. The document aims to educate students on the development, formulation, and performance of oral tablet dosage forms.Posology and dosage regimen
Posology and dosage regimenSandeepkarki13
油
It includes the detail information about the different dosage form along with its example and the factors affecting the choice of different dosage form.understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...MaryRoseFraga
油
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics-and-their-clinical-applications.pdfpatrial
patrialNadia Nabila Anam Arin
油
The document provides an overview of oral controlled release drug delivery systems. It discusses the anatomy and physiology related to oral drug administration. Some key advantages of controlled release oral dosage forms are enhanced bioavailability, reduced dosing frequency, and more consistent drug levels in the body. The document also covers various mechanisms for controlled release, including osmotic pumps, floating systems, and coating technologies. It provides examples of commercially available controlled release drugs and classifications of these systems.biopharmaceutices introduction.pptx
biopharmaceutices introduction.pptxanumalagundam sreekanth
油
Biopharmaceutics studies the impact of drug and drug product properties on delivery and performance in the body. The aim is to design drug products that provide optimal therapeutic effects and safety. Key considerations include drug bioavailability, properties like solubility that impact absorption, and dosage form design to deliver drugs effectively based on their characteristics and intended effects. Drug product design incorporates pharmacokinetic, manufacturing, and patient factors to successfully deliver therapeutic doses of drugs.Therequiv
Therequivcqpate
油
Bioavailability and bioequivalence are important concepts for regulating generic drugs. Bioavailability refers to the rate and extent that the active drug ingredient is absorbed and available in the body. Bioequivalence means two drug products containing the same active ingredient have the same rate and extent of absorption. For approval, generic drugs must demonstrate bioequivalence to the brand name drug through pharmacokinetic studies comparing metrics like AUC and Cmax between a test and reference drug. The FDA prefers showing bioequivalence through these types of studies using a crossover design in healthy subjects under fasted conditions.Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfShaikh Abusufyan
油
This document provides an introduction to pharmacology. It defines key terms like pharmacology, pharmacodynamics, pharmacokinetics, and discusses the history and divisions of pharmacology. It also covers drug nomenclature, essential medicines, orphan drugs, and provides definitions of related terms like pharmacy, pharmaceutics, and toxicology. The document is presented by Prof. Shaikh Abusufiyan and aims to explain fundamental concepts in pharmacology to students.Bioavailability & Bioequivalance
Bioavailability & BioequivalanceVNS Group of Institutions - Faculty of Pharmacy, Bhopal (M.P.) India
油
This document discusses bioavailability and bioequivalence. It defines bioavailability as the rate and extent of drug absorption into systemic circulation from its dosage form. Bioequivalence is established when two similar dosage forms reach systemic circulation at the same relative rate and extent. The objectives, significance, and various study designs of bioavailability testing are described, including absolute vs relative bioavailability. Methods for measuring bioavailability and various in vitro drug dissolution models are also summarized.Application of bio-pharmaceutics in the pharmaceutical industry
Application of bio-pharmaceutics in the pharmaceutical industryMd. Masum Billah
油
This presentation discusses the application of bio-pharmaceutics in the pharmaceutical industry. It defines bio-pharmaceutics as the study of a drug's physical and chemical properties and how they relate to the drug's effects over time. The presentation covers pharmacodynamics, pharmacokinetics, and some key applications including dose, dosage form, bioavailability, bioequivalence, and new drug development. It also discusses concepts such as volume of distribution, distribution coefficient, and organ-specific clearance.Bioavailability & Bioequivalance
Bioavailability & BioequivalanceVNS Group of Institutions - Faculty of Pharmacy, Bhopal (M.P.) India
油
Lect 1 introduction_to_dosage_form_design_
- 1. Introduction to Dosage Form Design Abubakr O. Nur (M.Pharm; PhD) Assoc. Prof. in Pharmaceutics (U of K) August 2010
- 2. Introduction What the course aim at? What are pharmaceutical processing, drug formulation and biopharmaceutics? Why DS or a dosage form for a drug? 2Dr. Abubakr O. Nur
- 3. You are already familiar with the following terms: Route of administration, bioavailability, bioequivalence, biopharmaceutics, rate and extent of drug absorption, onset of drug action, first pass effect, dissolution and disintegration. Are you????? 3Dr. Abubakr O. Nur
- 4. In fact, to design a dosage form three factors contribute similarly. 1. Dosage form related factors 2. Drug related factors 3. Physiological factors 4Dr. Abubakr O. Nur
- 5. Dosage forms to be considered are: Solid dosage forms (tablets and capsules) Liquid dosage forms (solution, suspensions and emulsions) Gas delivery (aerosols and inhalations) Semisolid delivery systems (dermatological products) Products for Transdermal applications (skin patches) Sustained and novel DDS. Sterile products 5Dr. Abubakr O. Nur